Fayez Sarofim & CO Edwards Lifesciences Corp Transaction History

Fayez Sarofim & CO

$41.7 Billion
Q3 2025

A detailed history of Fayez Sarofim & CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fayez Sarofim & CO holds 10,477 shares of EW stock, worth $904,165. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,477

Previous 10,477 -0.0%

Holding current value

$904,165

Previous $819,000 0.61%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$67.95 - $76.19 $222,740 - $249,750	-3,278 Reduced 23.83%	10,477 $759,000
Q4 2024 Feb 14, 2025	SELL	$64.54 - $75.92 $13,553 - $15,943	-210 Reduced 1.5%	13,755 $1.02 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $98,612 - $124,260	-1,598 Reduced 10.27%	13,965 $1.06 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $173,200 - $233,450	-2,500 Reduced 13.84%	15,563 $1.08 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $57,394 - $66,502	-705 Reduced 3.76%	18,063 $1.7 Million

Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $7,797 - $8,873	-105 Reduced 0.56%	18,768 $1.55 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $39,790 - $59,004	-460 Reduced 2.38%	18,873 $1.8 Million
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $68,395 - $84,027	-643 Reduced 3.22%	19,333 $2.51 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $298,470 - $372,945	-3,560 Reduced 15.13%	19,976 $2.07 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $269,872 - $310,998	3,430 Added 17.06%	23,536 $1.97 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $28,354 - $36,899	422 Added 2.14%	20,106 $1.61 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $804,524 - $1.08 Million	13,982 Added 245.21%	19,684 $1.36 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $89,123 - $102,037	1,243 Added 27.88%	5,702 $1.33 Million
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $74,413 - $91,194	1,209 Added 37.2%	4,459 $981,000
Q2 2019 Aug 09, 2019	BUY	$55.74 - $64.41 $10,590 - $12,237	190 Added 6.21%	3,250 $600,000
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $6,704 - $8,967	140 Added 4.79%	3,060 $585,000
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $6,497 - $7,971	-140 Reduced 4.58%	2,920 $447,000
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $129,897 - $156,978	3,060 New	3,060 $445,000

Others Institutions Holding EW

# of Institutions

1,460

Shares Held

469M

Call Options Held

3.46M

Put Options Held

4.07M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account